Impact of the antiproliferative agent ciclopirox olamine treatment on stem cells proteome

doi:10.4252/wjsc.v5.i1.9

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 5, Issue 1

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5162)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-8) series, Tables (1-9) series.

Item

Count

PDF

394

HTML

4281

Figures (1-8)

255

Tables (1-9)

232

Sum=5162

Jan 26, 2013 (publication date) through Nov 27, 2024

Times Cited of This Article

Times Cited (6)

Journal Information of This Article

Publication Name

World Journal of Stem Cells

ISSN

1948-0210

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Original Article

World J Stem Cells. Jan 26, 2013; 5(1): 9-25
Published online Jan 26, 2013. doi: 10.4252/wjsc.v5.i1.9

Full Size Figure Download Figure

Figure 1 Embryonic stem cells control vs ciclopirox olamine treated cells. Overlay of 2-DE gels of samples from ciclopirox olamine treated embryonic stem cells (ESCs) (orange) compared to control ESCs (blue). The identified proteins are indicated with the gene names.

Citation: Dihazi GH, Bibi A, Jahn O, Nolte J, Mueller GA, Engel W, Dihazi H. Impact of the antiproliferative agent ciclopirox olamine treatment on stem cells proteome. World J Stem Cells 2013; 5(1): 9-25
URL: https://www.wjgnet.com/1948-0210/full/v5/i1/9.htm
DOI: https://dx.doi.org/10.4252/wjsc.v5.i1.9